After draft notice mistakenly sent to Medicare contractors

Stakeholders Guess At Part B Drug Policies That CMS Might Test

By John Wilkerson / February 17, 2016 at 6:42 PM

Since CMS let slip Feb. 5 that it is considering a Part B drug reimbursement demonstration, lobbyists and consultants are reviewing potential policies that the agency might test, including options from last year’s report by the Medicare Payment Advisory Commission (MedPAC).


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.